OPTIMIZE Study Reports Lowest TLR Ever Achieved in an Investigational Device Exemption (IDE) Study With Svelte Medical System’s Bioresorbable Coated Drug-Eluting Coronary Stent

NEW PROVIDENCE, N.J.–(BUSINESS WIRE)–OPTIMIZE Study Reports Lowest TLR Ever Achieved in an IDE Trial with Svelte Medical System’s Bioresorbable Coated Drug-Eluting Coronary Stent